SWK
56
3
SRCL
70
12
COST
74
2
HSY
45
-3
L
67
15
AAL
20
2
MA
60
3
ITW
58
3
NKE
42
3
GRMN
58
2
CF
36
3
PFE
21
-4
WAT
37
-4
NVDA
66
-2
KMX
58
4
HON
57
4
SO
66
-2
ADBE
62
-2
VLO
35
2
SJM
36
2
SWK
56
3
SRCL
70
12
COST
74
2
HSY
45
-3
L
67
15
AAL
20
2
MA
60
3
ITW
58
3
NKE
42
3
GRMN
58
2
CF
36
3
PFE
21
-4
WAT
37
-4
NVDA
66
-2
KMX
58
4
HON
57
4
SO
66
-2
ADBE
62
-2
VLO
35
2
SJM
36
2
Financhill
Back

NovoCure Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
32

NVCR
NovoCure

Last Price:
19.42
Seasonality Move:
15.72%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Sell
32
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $19.40. The Score for NVCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $19.40
    The current trend is moderately bearish and NVCR is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.68 Buy
Relative Strength Index (14 RSI): 43.36 Sell
Chaikin Money Flow: -1183540 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.6 - 23.24) Sell
Bollinger Bands (100): (12.88 - 19.84) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.26 Sell
20-day SMA: 22.22 Sell
50-day SMA: 17.77 Buy
200-day SMA: 15.5 Buy
8-day EMA: 21.16 Sell
20-day EMA: 21.09 Sell
50-day EMA: 19.03 Buy
200-day EMA: 21.88 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.11 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):